After a huge IPO and acquisition, Zymergen caps off bankruptcy with $30M SEC penalty

The rise and fall of the short-lived biotech Zymergen has ended with a $30 million penalty from the SEC.

Zymergen’s rise began in April 2021 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Cordyceps sinensis shows promise in treating sepsis-associated acute kidney injury

Announcing a new publication for Acta Materia Medica journal. Cordyceps sinensis (CS) has been widely used as a dietary supplement or traditional medicine for the

August 7, 2024

Clean needles save lives. In some states, they might not be legal.

Kim Botteicher hardly thinks of herself as a criminal. On the main floor of a former Catholic church in Bolivar, Pennsylvania, Botteicher runs a flower

May 17, 2024

Adjusting forecast for the current fiscal year – Biotech Investments

MeVis Medical Solutions AG / Key word(s): Change in Forecast MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year 31-Jul-2023 / 16:27 CET/CEST

August 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.